ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

UiPath to Showcase How Agentic Automation is Transforming the Healthcare Industry at ViVE 2025 Conference

UiPath demoing agentic automation capabilities at booth #738 at ViVE 2025, February 17-19 in Nashville

UiPath (NYSE: PATH), a leading enterprise automation and AI software company, today announced it is exhibiting at the ViVE 2025 conference in Nashville from February 17-19, 2025 to showcase how agentic automation is empowering healthcare organizations to streamline operations, improve outcomes, and unlock new levels of productivity. The company will exhibit its Agentic Automation capabilities at booth #738.

Agentic Automation uses both robots and agents to complete more complex work tasks. The combination of robots and agents extends the capabilities and impact of automation, leading to business growth and empowering healthcare organizations to allow employees to work on value-added projects, reduce burnout-inducing manual tasks, and improve patient care. In healthcare, agents can be used by healthcare organizations for various tasks including medical policy QA, revenue cycle management, denial management, claims and care management, risk adjustment, medical record summarization and more.

“At ViVE, we look forward to showcasing how healthcare organizations can apply agentic automation to dynamic workflows to fully automate previously manual processes that were largely time consuming. Not only does this enable staff to make faster and more informed decisions but this allows them to spend more time on higher value processes and improve patient care while reducing administrative burdens,” said Jason Warrelmann, Vice President of Industry Practice at UiPath. “Agentic automation provides paramount value to healthcare organizations. For example, in medical record summarization it could take a clinician 30 minutes to an hour or even longer to summarize a patient’s medical records while an agent can complete this task in just a matter of minutes and instantly take action across the electronic medical records – leading to reduced errors, increase throughput, and lowered costs.”

Warrelmann will be joined by Mayo Clinic’s Biju Samkutty, COO of International & Enterprise Automation and Dr. Anjali Bhagra, Physician Lead and Chair of Enterprise Automation, at 10am CST on February 17, to discuss Mayo Clinic’s automation journey with UiPath. The discussion will dive into how Mayo Clinic is scaling automation, enhancing resilience, and improving patient care while reducing administrative burdens. Additionally, Warrelmann will present on stage at 1:20 pm CST on February 17 about how agentic automation, combined with robotic process automation, empowers healthcare organizations to attain value from AI. Attendees will gain an inside look at the most impactful AI-driven agents being developed for healthcare and walk away with a clear roadmap for prioritizing high-value solutions that drive transformation today.

ViVE attendees can visit UiPath at booth #738. To learn more about UiPath’s solutions for healthcare, visit https://www.uipath.com/solutions/industry/healthcare-automation.

About UiPath

UiPath (NYSE: PATH) develops AI technology that mirrors human intelligence with ever-increasing sophistication, transforming how businesses operate, innovate, and compete. The UiPath Platform™ accelerates the shift toward a new era of agentic automation—one where agents, robots, people, and models integrate seamlessly to drive autonomy and smarter decision-making. With a focus on security, accuracy, and resiliency, UiPath is committed to shaping a world where AI enhances human potential and revolutionizes industries. For more information, visit www.uipath.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.